Latest News about GSK
Recent news which mentions GSK
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug
March 30, 2023
From Benzinga
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
March 29, 2023
From Benzinga
GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients
March 28, 2023
From Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
From Benzinga
From Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
From Benzinga
From InvestorPlace
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
March 17, 2023
From Motley Fool
GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales
March 15, 2023
From Benzinga
From InvestorPlace
Tickers
GSK
From Motley Fool
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's
March 02, 2023
From Benzinga
3 Crucial Things to Know About Moderna Right Now
February 27, 2023
From Motley Fool
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
February 24, 2023
Tickers
GSK
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
February 23, 2023
From Benzinga
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows
February 23, 2023
From Benzinga
Intel and 9 Other Companies With Dividend Cuts in 2023
February 22, 2023
From InvestorPlace
My 3 Biggest Stock Market Predictions for March
February 21, 2023
From Motley Fool
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
From Benzinga
JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals
February 15, 2023
From Benzinga
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
February 14, 2023
From Benzinga
FDA AdComm Votes In Favor Of GSK's Jemperli Single Arm Trial Plan For Rectal Cancer Setting
February 10, 2023
Tickers
GSK
From Benzinga
FDA Grants Complete Approval For GSK's Jemperli For Endometrial Cancer
February 10, 2023
Tickers
GSK
From Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
From Benzinga
GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
February 01, 2023
Tickers
GSK
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.